A double-blind, multicentric, multinational randomised study to assess the effects of two years administration of 2 g per day of strontium ranelate versus alendronate 70 mg per week in women with postmenopausal osteoporosis on bone geometry and bone strength measured by peripheral-Quantitative Computed Tomography (p-QCT).
- Registry ID
- EUCTR2007-001509-11
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE3
- Sponsor
- Institut de Recherches Internationales Servier
- Start date
- 2007-10-15
- Completion date
- 2011-04-07
- Last update
- 2026-08-16
Conditions
- postmenopausal osteoporosis
- Post-menopausal osteoporosis
Summary
To assess the effects of strontium ranelate in comparison with alendronate (both treatment with calcium and vitamin D supplement) on the bone geometry and bone strength in postmenopausal osteoporotic women.
Locations
- , , Italy
- , , Sweden
- , , Greece
- , , Germany
View on source registry